Lifespan In Parkinson’s Nearly Identical To General Population
A new study finds that, overall, lifespan for those living with Parkinsons disease is nearly identical to those in the general population. The study looked at a group of diseases called synucleinopathies, including Parkinsons. The results appear in the May 15 online edition of JAMA Neurology.
Lewy bodies clumps of alpha-synuclein protein that accumulate in certain brain cells are the hallmark of PD. The clumps also occur in less common diseases such as multiple system atrophy , dementia with Lewy bodies , and PD dementia in which symptoms can be similar to those of typical Parkinsons.
Researchers led by Rodolfo Savica, M.D., Ph.D., at the Mayo Clinic in Rochester, MN, compared lifespan and cause of death among people with synucleinopathies compared to the general population. They examined the medical records of all 461 people diagnosed with synucleinopathies in Olmsted County, MN, between 1991 and 2010. The scientists also analyzed records from individuals closely matched for age and sex who did not have these diagnoses.
What Does It Mean?
Overall, the study reminds us that people with Parkinsons can live many years with the disease. With that in mind, people living with these diseases, their care partners and their families can take steps to plan for their health care and make important financial decisions.
Quality Of Life Problems
While talking about quality of life, we should say that Parkinsons disease patients deal with the biggest health issue in the form of depression. This problem detracts patients from their abilities to lead a full and a happy life. Only thing that family members of depressed Parkinsons disease patients should do is to keep a proper track on different depression signs and make sure to schedule appointment with a doctor on a regular basis for necessary treatments.
Drugs And Medication Used To Treat Parkinsons Disease
A number of different drugs can be used to treat Parkinsons.
Levodopa is the most common treatment for Parkinsons. It helps to replenish dopamine.
About 75 percent of cases respond to levodopa, but not all symptoms are improved. Levodopa is generally given with carbidopa.
Carbidopa delays the breakdown of levodopa which in turn increases the availability of levodopa at the blood-brain barrier.
Dopamine agonists can imitate the action of dopamine in the brain. Theyre less effective than levodopa, but they can be useful as bridge medications when levodopa is less effective.
Drugs in this class include bromocriptine, pramipexole, and ropinirole.
Anticholinergics are used to block the parasympathetic nervous system. They can help with rigidity.
Benztropine and trihexyphenidyl are anticholinergics used to treat Parkinsons.
Amantadine can be used along with carbidopa-levodopa. Its a glutamate-blocking drug . It offers short-term relief for the involuntary movements that can be a side effect of levodopa.
Catechol O-methyltransferase inhibitors prolong the effect of levodopa. Entacapone and tolcapone are examples of COMT inhibitors.
Tolcapone can cause liver damage. Its usually saved for people who do not respond to other therapies.
Ectacapone does not cause liver damage.
Stalevo is a drug that combines ectacapone and carbidopa-levodopa in one pill.
Read Also: How Do You Stop Parkinson’s Tremors
Parkinson’s Patients Can Have A Normal Life Span
THURSDAY, Nov. 1, 2018 — If thinking skills aren’t affected, a person with Parkinson’s disease can live a normal life span, a new study suggests.
“This is good news for many people with Parkinson’s and their families,” study author Dr. David Backstrom, from Umea University in Sweden, said in a news release from the American Academy of Neurology.
Parkinson’s is a progressive nervous system disorder that affects movement. It was generally believed that Parkinson’s did not affect life expectancy, but recent studies have found a somewhat shorter life span for people with the disease.
Seeking clarification, Backstrom’s team looked at 182 patients newly diagnosed with Parkinson’s disease or other types of parkinsonism. The study patients were followed for nearly 14 years.
The patients’ mental abilities were tested at the start of the study period and annually after that. During the study, 109 participants died.
Those who had problems with memory and thinking skills at the start of the study were more than twice as likely to die during the follow-up period than people who didn’t have these problems, the investigators found.
Average age at the study’s start was about 71 for people with Parkinson’s disease. Expected survival for people with no mild cognitive impairment was nearly 12 years, compared with just over 8 years for those with mild cognitive impairment, the findings showed.
The study was published online Oct. 31 in Neurology.
Myth : Parkinsons Is Only A Motor Condition
Fact: While its true that Parkinsons disease symptoms include shaking and tremor, rigid muscles, slowness of movement, and a frozen or flat expression, its a lot more than that.
Nonmotor symptoms deserve and are getting more attention from doctors and researchers. These symptoms include cognitive impairment or dementia , anxiety and depression, fatigue, sleep problems and more.
For some patients, nonmotor symptoms are more disabling than motor symptoms, which are the focus of treatment. Be sure to talk to your doctor about other issues so you can get all of your symptoms addressed.
Recommended Reading: Nasal Spray For Parkinson’s
What Is Parkinsons Disease
Parkinsons disease is a progressive brain disorder that affects mobility and mental ability. If you or a loved one has been diagnosed with Parkinsons, you may be wondering about life expectancy.
According to some research, on average, people with Parkinsons can expect to live almost as long as those who dont have the condition.
Micrographia: Having Small Handwriting
Having small handwriting may seem like an unexpected aspect of Parkinsons, but it is quite common. Many people actually experience this symptom as one of their first signs of PD, years before other movement symptoms arrive. It is literally what the name describes: When you hold a pen or pencil and write on a sheet of paper, your numbers and letters are very small and cramped-looking. It is caused by a lack of dopamine in the part of your brain called the basal ganglia, which helps start and control your movements.25 Without dopamine, the neurons in the basal ganglia cannot communicate with each other to produce smooth, controlled movement.
Don’t Miss: Early Signs Of Parkinson’s Disease Nhs
Who Gets Parkinsons Disease
Risk factors for PD include:
- Age. The average age of onset is about 70 years, and the incidence rises significantly with advancing age. However, a small percent of people with PD have early-onset disease that begins before the age of 50.
- Sex. PD affects more men than women.
- Heredity. People with one or more close relatives who have PD have an increased risk of developing the disease themselves. An estimated 15 to 25 percent of people with PD have a known relative with the disease. Some cases of the disease can be traced to specific genetic mutations.
- Exposure to pesticides. Studies show an increased risk of PD in people who live in rural areas with increased pesticide use.
How Long Does It Take For Focal Dystonia To Get Worse
Dystonia is an unpredictable condition. It tends to progress slowly and the severity of a persons symptoms can vary from one day to another. Focal dystonia usually progresses gradually over a period of about five years and then doesnt get any worse. Sometimes, a persons symptoms improve or disappear completely.
Read Also: Are Hallucinations A Symptom Of Parkinson’s
Life Expectancy And Dementia With Lewy Bodies
Dementia with Lewy bodies accounts for around 7% of cases of dementia. Lewy bodies are tiny protein deposits that affect thought, memory and movement and are linked to both dementia and Parkinsons disease.
Hallucinations, sleep disturbance, and movement problems can be an early feature in dementia with Lewy bodies, so that diagnosis may be made at an earlier stage. Some research suggests that survival can be significantly shorter with this challenging condition, however, the Alzheimers Society says:
Drugs To Lower Blood Sugar Levels
High blood sugar is the source of all diseases.If the sugar in the blood does not drop properly, it can damage the blood vessels and eventually cause a shortened life span.This is where the drug is used.It stimulates the secretion of insulin, and is prescribed to bring blood sugar levels back to normal.Glibenclamide and chlorpropamide are typical examples.
The reason this drug is so dangerous is that it can trigger hypoglycemic symptoms in some middle-aged and older people.Specifically, headaches, tremors, severe fatigue, and in the worst cases, loss of consciousness can occur.If possible, avoid using this medication as well, and consult with your doctor to see if there are any alternatives that can be used.
How Can I Identify Dangerous Drugs
First, let’s talk about the reliability of scientific data.If you’re not used to looking at data, it can be difficult to figure out, What information should I believe? If you’re not used to looking at data, it can be difficult to figure out which information to believe.In particular, studies on drugs and supplements often have conflicting results, and there are few safety tests for middle-aged and older people to begin with.Is there nothing we can do about it?
Of course, that’s not true.Fortunately, some clear standards have been established on the question, What drugs are dangerous to take? Fortunately, some clear standards have been established on the issue of what kind of medicine is dangerous to take?That’s the Beers List.
This list was created by Dr. Mark Beers in the US in 1991.Dr. Beers, who had long been troubled by the number of medication problems among his elderly patients, checked a large amount of data available at the time and compiled a list of dangerous drugs to take.
The list has since been passed on to the next generation of doctors, and is still being updated regularly to incorporate the latest data.While there is little data available for middle-aged and elderly people, this is the best data possible and is the most reliable list available at the moment.
So, let’s now check out the drugs that cause the most damage to the body, referring to the latest version of the Beers List.Please refer to this page while checking the medication you are using.
What Is The Prognosis And Life Expectancy For Parkinson’s Disease
The severity of Parkinson’s disease symptoms and signs vary greatly from person to person, and it is not possible to predict how quickly the disease will progress.
- Parkinson’s disease itself is not a fatal disease, and the average life expectancy is similar to that of people without the disease.
- Secondary complications, such as pneumonia, falling-related injuries, and choking can lead to death.
- Many treatment options can reduce some of the symptoms and prolong the quality of life.
You May Like: Can You Drive With Parkinsons
Signs Of Parkinsons Disease
In 1817, Dr. James Parkinson published An Essay on the Shaking Palsy describing non-motor, as well as, motor symptoms of the illness that bears his name. Parkinsons is not just a movement disorder, explained Dr. Shprecher. Constipation, impaired sense of smell, and dream enactment can occur years before motor symptoms of Parkinsons. The latter, caused by a condition called REM sleep behavior disorder, is a very strong risk factor for both Parkinsons and dementia . This has prompted us to join a consortium of centers studying REM sleep behavior disorder.
If You Live In South Jersey And Have Questions About The Final Stages Of Parkinsons Disease Or Hospice Care For Your Loved One Please Call Samaritan At 229
Samaritan is a member of the National Partnership for Healthcare and Hospice Innovation, a network of not-for-profit hospice and palliative providers across the country. If you know someone outside of our service area who is living with advanced illness and can benefit from hospice or palliative care, please call 1 -GET-NPHI for a referral to a not-for-profit provider in your area.
Don’t Miss: Parkinson’s Disease And Cognition
When To Seek Hospice Care
When you or your loved one have a life expectancy of six months or less, you become eligible for hospice care a type of comfort care provided at the end of life for someone living with end-stage Parkinsons disease. Hospice provides extra support so your loved one can live as comfortably as possible.
If you have experienced a significant decline in your ability to move, speak, or participate in activities of daily living without caregiver assistance, its time to speak with a hospice professional.
Some of the things that determine whether your loved one with end-stage Parkinsons is eligible for hospice include: difficulty breathing, bed bound, unintelligible speech, inability to eat or drink sufficiently, and/or complications including pneumonia or sepsis.
If you live in South Jersey, our nurse care coordinator can answer your questions and decide if your loved one is ready for hospice care. Call us 24/7 at 229-8183.
Reported Standardised Mortality Ratios From 1935 To 2001
The SMRs or mortality ratios comparing PD cases and controls from 39 studies from 1935 to 2006 are reported in table 1. The SMRs ranged from 1, indicating no differences compared with the general population, to 3.4, indicating more than threefold higher mortality in PD. The time trend of estimates is inconsistent, although there appears to be a decrease in the 1970s, corresponding to the introduction of levodopa trials during that time period .). A geographical trend is not apparent, as the SMRs within each geographical region are as variable as between regions .
Table 1Summary of studies that have reported a standardised mortality ratio, comparing Parkinson’s disease patients with a general population
Figure 1Standardised mortality ratios for Parkinson’s disease from 39 studies by publication date.
Read Also: Insomnia And Parkinson’s Disease
History Of Parkinsons Disease
Symptoms and possible treatments for Parkinsons were discussed in texts related to Ayurveda, an ancient Indian medical practice thats been around since as early as 5,000 B.C. A Parkinsons-like condition was also mentioned in the first Chinese medical text, the Huangdi Neijing, more than 2,500 years ago.
Parkinsons disease was formally recognized in an 1817 paper, An Essay on the Shaking Palsy, by James Parkinson, a London apothecary-surgeon and member of the Royal College of Surgeons. 30644-5/fulltext” rel=”nofollow”> 3)
Parkinson observed what are now known as the classic symptoms of Parkinson’s disease, including tremors, rigidity, and postural instability. He theorized that the disease developed because of a problem in the brains medulla region.
Parkinsons essay received little attention until 1861, when French neurologist Jean-Martin Charcot and his colleagues distinguished the disease from other neurological conditions and termed it Parkinson’s disease.
What Are The Types Of Progressive Supranuclear Palsy
There are many types of PSP but the two most common types are Richardson syndrome and PD-like variant which means a Parkinsons disease-variant. Together, they make up 75% of PSP cases. The symptoms are similar, but there are some unique differences.
Richardson syndrome has many symptoms including problems with walking and balance, abnormal speech, memory and thinking problems, trouble controlling eye movement and an unusual wide-eyed, staring facial expression. People with Richardson syndrome also have personality changes, forgetfulness, apathy , depression, irritability and problems with attention and concentration. These are the most common symptoms.
PD-like variant consists of the above symptoms, but also more closely resembles Parkinsons disease. A tremor is the main symptom over balance problems and behavioral changes. PSP-parkinsonism responds better to antiparkinson drugs.
You May Like: Gifts For Parkinson’s Disease
Study Says Life Span Normal When Parkinson’s Does Not Affect Thinking
In the past, researchers believed that Parkinson’s disease did not affect life expectancy. But recent studies showed a somewhat shorter life span. Now a new study suggests that when the disease does not affect thinking skills early on, life span is not affected. The study is published in the October 31, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
“This is good news for many people with Parkinson’s and their families,” said study author David Bäckström, MD, of Umeå University in Umeå, Sweden.
The study looked at people with Parkinson’s disease and other types of parkinsonism, such as multiple system atrophy and progressive supranuclear palsy. People with those two disorders had the shortest life expectancy, with a mortality rate that was more than three times higher than for the general population.
The study involved 182 people who were newly diagnosed with parkinsonism and were followed for up to 13.5 years. Of the participants, 143 had Parkinson’s disease, 18 had progressive supranuclear palsy and 13 had multiple system atrophy. At the start of the study and at least once a year, the participants were tested for Parkinson’s symptoms and memory and thinking skills. During the study, 109 of the people died.
Other factors early in the disease that were associated with a shorter life span were having freezing of gait, where people are briefly unable to walk, and a loss of the sense of smell.
How Will My Doctor Test For It
There’s no one test for Parkinson’s. A lot of it’s based on your symptoms and health history, but it could take some time to figure it out. Part of the process is ruling out other conditions that look like Parkinson’s. The docotor may do a DaT scan, which looks for dopamine in the brain. This can aid in a diagnosis.
Because there is no single test, it’s very important to go to a doctor who knows a lot about it, early on. It’s easy to miss.
If you do have it, your doctor might use what’s called the Hoehn and Yahr scale to tell you what stage of the disease you’re in. It ranks how severe your symptoms are from 1 to 5, where 5 is the most serious.
The stage can help you get a better feel for where your symptoms fall and what to expect as the disease gets worse. But keep in mind, some people could take up to 20 years to move from mild to more serious symptoms. For others, the change is much faster.